Coman Diana, Coales Isabelle, Roberts Luke B, Neves Joana F
Centre for Host Microbiome Interactions, King's College London, London, United Kingdom.
School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
Front Immunol. 2022 Jun 23;13:903688. doi: 10.3389/fimmu.2022.903688. eCollection 2022.
Inflammatory bowel disease (IBD) is an idiopathic condition characterized by chronic relapsing inflammation in the intestine. While the precise etiology of IBD remains unknown, genetics, the gut microbiome, environmental factors, and the immune system have all been shown to contribute to the disease pathophysiology. In recent years, attention has shifted towards the role that innate lymphoid cells (ILCs) may play in the dysregulation of intestinal immunity observed in IBD. ILCs are a group of heterogenous immune cells which can be found at mucosal barriers. They act as critical mediators of the regulation of intestinal homeostasis and the orchestration of its inflammatory response. Despite helper-like type 1 ILCs (ILC1s) constituting a particularly rare ILC population in the intestine, recent work has suggested that an accumulation of intestinal ILC1s in individuals with IBD may act to exacerbate its pathology. In this review, we summarize existing knowledge on helper-like ILC1 plasticity and their classification in murine and human settings. Moreover, we discuss what is currently understood about the roles that ILC1s may play in the progression of IBD pathogenesis.
炎症性肠病(IBD)是一种特发性疾病,其特征为肠道慢性复发性炎症。虽然IBD的确切病因仍不清楚,但遗传学、肠道微生物群、环境因素和免疫系统均已被证明与该疾病的病理生理学有关。近年来,人们的注意力已转向固有淋巴细胞(ILC)在IBD中观察到的肠道免疫失调中可能发挥的作用。ILC是一组异质性免疫细胞,可在黏膜屏障处发现。它们是肠道稳态调节及其炎症反应协调的关键介质。尽管辅助样1型ILC(ILC1)在肠道中构成特别罕见的ILC群体,但最近的研究表明,IBD患者肠道中ILC1的积累可能会加剧其病理状况。在本综述中,我们总结了关于辅助样ILC1可塑性及其在小鼠和人类环境中的分类的现有知识。此外,我们讨论了目前对ILC1在IBD发病机制进展中可能发挥的作用的理解。